Health Knowledge, Attitudes, Practice, HIV/AIDS, STI
Conditions
Keywords
Transgender Women, STI, Sexual Health, HIV/AIDS
Brief summary
The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. The baseline and follow-up assessments will collect data on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcome measures are self-reported sexually transmitted infection (STI)/HIV testing and sex without a condom, with secondary measures including sexual risk behaviors, health care visits, perceived social support/connectedness, pre-exposure prophylaxis (PrEP) use, self-efficacy in negotiation/communication, and comfort with gender identity and appearance. In addition, process data, such as forum content, and usage data will be collected and analyzed.
Detailed description
A 2-arm cluster randomized controlled trial will be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. The Trans Women Connected intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths-based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP content, post-exposure prophylaxis (PEP) content, and communication forums. To be eligible, participants will be required to self-identify as transgender women; report having had 2 or more sexual partners in the past 90 days with at least one of those partners having a penis; be age 18-49 at baseline; own a smartphone; and reside in any state in the United States. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. Participants will be recruited using a variety of methods, including: 1) Regional transwomen recruitment/retention specialists who are responsible for facilitating recruitment in their regions, addressing study questions, and maintaining connections with each participant to support study engagement; 2) Organizations. Organizations from across the U.S., at least one per state, that serve transgender women will be approached to help recruit participants through social media and in-person. 3) Google Adwords. Placing study advertisements on Google based on keyword for participant recruitment has been shown to be effective. 4) Social Media Advertising including targeted advertising on social media sites (Facebook/Instagram) and sponsoring study posts with social media influencers in the Transwomen community. Social media advertising has been shown to be favorable in terms of its cost-effectiveness, usability, and reach, especially with hard-to-reach populations, young adults and lesbian, gay, bisexual, and transgender (LGBT) populations. 5) Participant Recruitment (participants sharing information about the study within their networks). Participants will complete 4 web-based surveys and will receive $20 for baseline survey, $20 for an immediate posttest, $40 at 3-month follow up, $60 at final 6-month follow up. Randomization. The 2-arm randomized controlled trial involves randomizing individual participants using an equal allocation (allocation ratio 1:1) to receive the full TWC app or an attention control app. Participants were randomized after completing their baseline surveys using the randomizer feature of Qualtrics. Data Collection. Participants will be surveyed at 4 time points. 1) before randomization, 2) after using the mobile app for 1 month, 3) three months after completion of the baseline, and 4) six months after completion of the baseline. Surveys will be completed online through emailed or texted links. Data will also be collected through the apps. This includes usage data, such as what activities participants used and for how long, and process data, which includes content on the communication forum, text answers in the app, and visual content such as vision boards. Participants will receive an incentive of $20 for the baseline and immediate post-intervention survey, $40 for the 3-month follow up survey, and $60 for the 6 month follow up survey. Study Hypotheses. Primary Hypotheses 1 (representing sexual health risk reduction through engagement in care 1) Women in the intervention group will report more STI testing (higher rates of STI testing in the prior 90 days) than the comparison group. Primary Hypotheses 2, women in the intervention group will report fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse. Secondary Hypotheses (representing other important sexual health risk, and psychosocial outcomes):1) Participants in the intervention group will report reduced sexual risk taking including fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse; greater use of condom use at last intercourse (receptive anal or vaginal); and increased use of PrEP for those that are HIV- 2) Participants in the intervention group will engage more with proactive health care and report more health care visits. 3) Participants in the treatment group will report more connectedness with other transgender women, including perceived social support and engagement with a mentor. 4) Participants in the intervention group will report greater efficacy in having safer sex and in communication both with partners and health care workers. 5) Those in the treatment group will have greater acceptance of their gender identity/comfort with gender identity.
Interventions
The intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP/PEP content, and communication forums.
The control group will download a mobile app that addresses COVID and provides COVID resources.
Sponsors
Study design
Masking description
Participants are randomly assigned to their condition without being made aware of their assigned condition. Each condition downloads and uses an app so study activities are similar reducing the likelihood participants will be aware of their assigned condition.
Intervention model description
This is a two arm randomized controlled trial. Implementation. After randomization, participants will be granted access to download and install their respective Trans Women Connected mobile apps (intervention or attention control).
Eligibility
Inclusion criteria
1. aged 18-49 at the start of the study. 2. self-identify as transgender women 3. self-identify as sexually active with more than one partner in the prior 90 days 4. at least one sexual partner in the last 90 days had a penis 5. has a smartphone 6. resides in the U.S.
Exclusion criteria
Anyone not meeting inclusion criteria
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Self-reported HIV or STI Testing in Past 3 Months | 3-months post intervention | Participant reported having tested for HIV or STI in the past 3 months |
| Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | 3-months post intervention | Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | 3-month post intervention | Participant reported using a condom at last receptive anal intercourse or vaginal intercourse |
| Health Care Visits in Past 3 Months | 3-months post intervention | Average # of self-reported visits to a health care provider (of any type and by type) |
| Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | 1-month post intervention | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. |
| Transgender Congruence Scale (TCS) | 1-month post intervention | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity |
| PrEP Uptake | 1-month post intervention | Self-reported uptake of PrEP among HIV since last measurement period- subsample |
| Condom/Barrier Negotiation Self Efficacy Scale | 1 month post-intervention | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy |
| Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | 1-month post intervention | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services |
| Engaged as/With Mentor in Past 3 Months | 3-months post intervention | Self-reported number of contacts in the past 3 months as a mentor/mentee for guidance or support |
| Trans Women Connected Satisfaction Survey | 1-month post intervention | Scale measures participants' reactions to the app. Average of 3 items on a 5-point scale with a range of 1 to 5 with a higher score indicating greater levels of satisfaction with the app. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| TWC App The intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women. | 275 |
| General Health App An alternate mobile app (TWC COVID only) was designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources. | 299 |
| Total | 574 |
Baseline characteristics
| Characteristic | General Health App | Total | TWC App |
|---|---|---|---|
| Age, Continuous | 31.49 years STANDARD_DEVIATION 7.88 | 31.54 years STANDARD_DEVIATION 7.86 | 31.59 years STANDARD_DEVIATION 7.85 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 78 Participants | 150 Participants | 72 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 221 Participants | 423 Participants | 202 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 1 Participants | 1 Participants |
| HIV test in past 3 months Not reported | 68 Participants | 131 Participants | 63 Participants |
| HIV test in past 3 months Not tested for HIV in past 3 months | 83 Participants | 158 Participants | 75 Participants |
| HIV test in past 3 months Tested for HIV in past 3 months | 148 Participants | 285 Participants | 137 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 12 Participants | 19 Participants | 7 Participants |
| Race (NIH/OMB) Asian | 13 Participants | 16 Participants | 3 Participants |
| Race (NIH/OMB) Black or African American | 90 Participants | 166 Participants | 76 Participants |
| Race (NIH/OMB) More than one race | 37 Participants | 76 Participants | 39 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 8 Participants | 14 Participants | 6 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 22 Participants | 41 Participants | 19 Participants |
| Race (NIH/OMB) White | 117 Participants | 242 Participants | 125 Participants |
| Receptive sex without condom in past 3 months Did not have receptive sex without a condom in past 3 months | 57 Participants | 116 Participants | 59 Participants |
| Receptive sex without condom in past 3 months Had receptive sex without a condom in past 3 months | 232 Participants | 440 Participants | 208 Participants |
| Receptive sex without condom in past 3 months Not reported | 10 Participants | 18 Participants | 8 Participants |
| Region of Enrollment United States | 299 participants | 574 participants | 275 participants |
| Sex/Gender, Customized Transgender woman | 299 participants | 574 participants | 275 participants |
| Sexual orientation Heterosexual | 78 Participants | 147 Participants | 69 Participants |
| Sexual orientation Not heterosexual | 221 Participants | 427 Participants | 206 Participants |
| STI test in past 3 months Not reported | 11 Participants | 21 Participants | 10 Participants |
| STI test in past 3 months Not tested for STI in past 3 months | 108 Participants | 214 Participants | 106 Participants |
| STI test in past 3 months Tested for STI in past 3 months | 180 Participants | 339 Participants | 159 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 275 | 0 / 299 |
| other Total, other adverse events | 0 / 275 | 0 / 299 |
| serious Total, serious adverse events | 0 / 275 | 0 / 299 |
Outcome results
Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months
Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months
Time frame: 6-months post intervention
Population: All participants completing baseline and 6-month follow up survey.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | 99 Participants |
| General Health App | Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | 96 Participants |
Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months
Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months
Time frame: 3-months post intervention
Population: All participants who completed baseline and 3-month follow-up surveys.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | 106 Participants |
| General Health App | Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | 101 Participants |
Self-reported HIV or STI Testing in Past 3 Months
Participant reported having tested for HIV or STI in the past 3 months
Time frame: 3-months post intervention
Population: All participants with baseline and 3-month follow-up survey.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | Self-reported HIV or STI Testing in Past 3 Months | 76 Participants |
| General Health App | Self-reported HIV or STI Testing in Past 3 Months | 88 Participants |
Self-reported HIV or STI Testing in Past 3 Months
Participant reported having tested for HIV or STI in the past 3 months
Time frame: 6-months post intervention
Population: All participants who completed baseline and 6-month follow-up surveys.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | Self-reported HIV or STI Testing in Past 3 Months | 77 Participants |
| General Health App | Self-reported HIV or STI Testing in Past 3 Months | 88 Participants |
Condom/Barrier Negotiation Self Efficacy Scale
Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy
Time frame: 6-month post intervention
Population: Participants completing baseline and 6-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Condom/Barrier Negotiation Self Efficacy Scale | 5.52 score on a scale | Standard Deviation 1.6 |
| General Health App | Condom/Barrier Negotiation Self Efficacy Scale | 5.55 score on a scale | Standard Deviation 1.54 |
Condom/Barrier Negotiation Self Efficacy Scale
Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy
Time frame: 1 month post-intervention
Population: Participants completing baseline and 1-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Condom/Barrier Negotiation Self Efficacy Scale | 5.40 score on a scale | Standard Deviation 1.58 |
| General Health App | Condom/Barrier Negotiation Self Efficacy Scale | 5.48 score on a scale | Standard Deviation 1.59 |
Condom/Barrier Negotiation Self Efficacy Scale
Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy
Time frame: 3- month post intervention
Population: Participants completing baseline and 3-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Condom/Barrier Negotiation Self Efficacy Scale | 5.63 score on a scale | Standard Deviation 1.51 |
| General Health App | Condom/Barrier Negotiation Self Efficacy Scale | 5.54 score on a scale | Standard Deviation 1.49 |
Engaged as/With Mentor in Past 3 Months
Self-reported number of contacts, in the past 3 months, as a mentor/mentee for guidance or support
Time frame: 6-months post intervention
Population: Participants completing baseline and 6-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Engaged as/With Mentor in Past 3 Months | 6.32 Number of mentor/mentee contacts | Standard Deviation 10 |
| General Health App | Engaged as/With Mentor in Past 3 Months | 3.25 Number of mentor/mentee contacts | Standard Deviation 1.55 |
Engaged as/With Mentor in Past 3 Months
Self-reported number of contacts in the past 3 months as a mentor/mentee for guidance or support
Time frame: 3-months post intervention
Population: Participants completing baseline and 3-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Engaged as/With Mentor in Past 3 Months | 5.35 Number of mentee/mentor contacts | Standard Deviation 8.53 |
| General Health App | Engaged as/With Mentor in Past 3 Months | 2.50 Number of mentee/mentor contacts | Standard Deviation 1 |
Health Care Visits in Past 3 Months
Average # of self-reported visits to a health care provider (of any type and by type)
Time frame: 3-months post intervention
Population: All participants completing baseline and 3-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Health Care Visits in Past 3 Months | 4.75 Number of visits | Standard Deviation 5.49 |
| General Health App | Health Care Visits in Past 3 Months | 5.02 Number of visits | Standard Deviation 4.94 |
Health Care Visits in Past 3 Months
Average # of self-reported visits to a health care provider (of any type and by type)
Time frame: 6-months post intervention
Population: All participants completing baseline and 6-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Health Care Visits in Past 3 Months | 4.63 Number of visits | Standard Deviation 4.54 |
| General Health App | Health Care Visits in Past 3 Months | 4.61 Number of visits | Standard Deviation 4.1 |
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services
Time frame: 6- month post intervention
Population: Participants completing baseline and 6-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | 3.18 score on a scale | Standard Deviation 0.88 |
| General Health App | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | 3.20 score on a scale | Standard Deviation 0.77 |
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services
Time frame: 1-month post intervention
Population: Participants completing baseline and 1-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | 3.14 score on a scale | Standard Deviation 0.86 |
| General Health App | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | 3.03 score on a scale | Standard Deviation 0.86 |
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services
Time frame: 3-month post intervention
Population: Participants completing baseline and 3-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | 3.17 score on a scale | Standard Deviation 0.88 |
| General Health App | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | 3.16 score on a scale | Standard Deviation 0.8 |
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.
Time frame: 6-month post intervention
Population: All participants completing baseline and 6-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | 3.46 score on a scale | Standard Deviation 1.14 |
| General Health App | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | 3.16 score on a scale | Standard Deviation 1.09 |
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.
Time frame: 1-month post intervention
Population: All participants completing baseline and 1-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | 3.23 score on a scale | Standard Deviation 1.18 |
| General Health App | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | 3.16 score on a scale | Standard Deviation 1.08 |
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.
Time frame: 3-month post intervention
Population: All participants completing baseline and 3-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | 3.30 score on a scale | Standard Deviation 1.15 |
| General Health App | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | 3.15 score on a scale | Standard Deviation 1.16 |
PrEP Uptake
Self-reported uptake of PrEP among HIV since last measurement period- subsample
Time frame: 1-month post intervention
Population: Participants completing baseline and 1-month follow-up survey.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | PrEP Uptake | 6 Participants |
| General Health App | PrEP Uptake | 13 Participants |
PrEP Uptake
Self-reported uptake of PrEP among HIV since last measurement period- subsample
Time frame: 6-month post intervention
Population: Participants completing baseline and 6-month follow-up survey.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | PrEP Uptake | 8 Participants |
| General Health App | PrEP Uptake | 4 Participants |
PrEP Uptake
Self-reported uptake of PrEP among HIV since last measurement period- subsample
Time frame: 3-month post intervention
Population: Participants completing baseline and 3-month follow-up surveys.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | PrEP Uptake | 8 Participants |
| General Health App | PrEP Uptake | 8 Participants |
Transgender Congruence Scale (TCS)
Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity
Time frame: 6-month post intervention
Population: Participants completing baseline and 6-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Transgender Congruence Scale (TCS) | 3.66 score on a scale | Standard Deviation 0.9 |
| General Health App | Transgender Congruence Scale (TCS) | 3.51 score on a scale | Standard Deviation 0.92 |
Transgender Congruence Scale (TCS)
Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity
Time frame: 1-month post intervention
Population: Participants completing baseline and 1-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Transgender Congruence Scale (TCS) | 3.65 score on a scale | Standard Deviation 0.94 |
| General Health App | Transgender Congruence Scale (TCS) | 3.46 score on a scale | Standard Deviation 0.91 |
Transgender Congruence Scale (TCS)
Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity
Time frame: 3-month post intervention
Population: Participants completing baseline and 3-month follow-up surveys.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Transgender Congruence Scale (TCS) | 3.61 score on a scale | Standard Deviation 0.93 |
| General Health App | Transgender Congruence Scale (TCS) | 3.51 score on a scale | Standard Deviation 0.95 |
Trans Women Connected Satisfaction Survey
Scale measures participants' reactions to the app. Average of 3 items on a 5-point scale with a range of 1 to 5 with a higher score indicating greater levels of satisfaction with the app.
Time frame: 1-month post intervention
Population: Participants completing 1-month follow-up survey.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| TWC App | Trans Women Connected Satisfaction Survey | 4.06 score on a scale | Standard Deviation 0.96 |
| General Health App | Trans Women Connected Satisfaction Survey | 3.58 score on a scale | Standard Deviation 1.2 |
Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse
Participant reported using a condom at last receptive anal intercourse or vaginal intercourse
Time frame: 3-month post intervention
Population: All participants who completed baseline and 3-month follow-up surveys.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | 55 Participants |
| General Health App | Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | 51 Participants |
Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse
Participant reported using a condom at last receptive anal intercourse or vaginal intercourse
Time frame: 6-month post intervention
Population: All participants who completed baseline and 6-month follow-up surveys.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| TWC App | Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | 48 Participants |
| General Health App | Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | 52 Participants |